2015
DOI: 10.1021/nn5063613
|View full text |Cite
|
Sign up to set email alerts
|

A Yolk-like Multifunctional Platform for Multimodal Imaging and Synergistic Therapy Triggered by a Single Near-Infrared Light

Abstract: To integrate photodynamic therapy (PDT) with photothermal therapy (PTT) and chemotherapy for enhanced antitumor efficiency, we developed a mild and rational route to synthesize novel multifunctional GdOF:Ln@SiO2 (Ln = 10%Yb/1%Er/4%Mn) mesoporous capsules using strong up-conversion luminescent (UCL) GdOF:Ln as cores and mesoporous silica layer as shells, followed by modification with varied functional groups onto the framework. It was found that due to the codoped Yb/Er/Mn in GdOF, the markedly enhanced red emi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
212
0

Year Published

2015
2015
2017
2017

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 318 publications
(212 citation statements)
references
References 73 publications
0
212
0
Order By: Relevance
“…The recent leap is the combined onco-therapeutic technique which is employed for targeting cancers through multiple mechanisms, for instance, a combination of targeted drug delivery and photodynamic therapy (PDT). Specifically, this strategy tends to target various prime signal transduction pathways for the amplification of fused therapeutic efficacy [3]. This combination may also give rise to synergistic effects thereby, leading to a reduction of the dose of the drug for enhanced feasibility, thereby undermining side effects usually associated with chemotherapeutic agents like doxorubicin (DOX) [4].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…The recent leap is the combined onco-therapeutic technique which is employed for targeting cancers through multiple mechanisms, for instance, a combination of targeted drug delivery and photodynamic therapy (PDT). Specifically, this strategy tends to target various prime signal transduction pathways for the amplification of fused therapeutic efficacy [3]. This combination may also give rise to synergistic effects thereby, leading to a reduction of the dose of the drug for enhanced feasibility, thereby undermining side effects usually associated with chemotherapeutic agents like doxorubicin (DOX) [4].…”
Section: Introductionmentioning
confidence: 99%
“…The progressing possibilities have given rise to the employment of light-elicited release of chemotherapeutics from photo-responsive nanoparticles (NPs); bearing the capacity to eradicate malignant cells by drawing in external electromagnetic energy [3]. Therefore, the light and chemotherapeutic agent combination is a preeminently stimulating methodology focusing on optimised cancer treatment.…”
Section: Introductionmentioning
confidence: 99%
“…Combined treatments may target different key signal transduction pathways in order to amplify overall therapeutic efficacy. 8,9 This may result in synergistic effects, so that a reduction of the drug dose becomes feasible, may eliminate or at least reduce the side effects usually caused by chemotherapeutic agents such as doxorubicin (DOX). 10,11 A progressively emerging system in such efforts is the lighttriggered release of chemotherapeutics from light-responsive nanocarriers; capable enough to damage or destroy malignant tissues by absorbing external electromagnetic energy.…”
Section: Introductionmentioning
confidence: 99%
“…10,11 A progressively emerging system in such efforts is the lighttriggered release of chemotherapeutics from light-responsive nanocarriers; capable enough to damage or destroy malignant tissues by absorbing external electromagnetic energy. [8][9][10][11] Thus, the combination of light and chemotherapeutic agents is a predominantly encouraging methodology for optimizing cancer treatment. Such light-triggered drug release can easily be combined with the photodynamic or photothermal modes, ensuring enhanced cancer cell killing through combination therapy.…”
Section: Introductionmentioning
confidence: 99%
“…They have been recently emerged as optical imaging nanoprobes and magnetic resonance image contrast agents for magnetic/optical bimodal detection [13][14][15][16] The upconversion luminescence is usually studied by using the trivalent Er 3+ ions as activators because the metastable levels 4 I 9/2 and 4 I 11/2 can be conveniently populated 17 .…”
mentioning
confidence: 99%